The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat

Journal of Medicinal Chemistry
Kevin W KuntzRichard Chesworth

Abstract

Posttranslational methylation of histones plays a critical role in gene regulation. Misregulation of histone methylation can lead to oncogenic transformation. Enhancer of Zeste homologue 2 (EZH2) methylates histone 3 at lysine 27 (H3K27) and abnormal methylation of this site is found in many cancers. Tazemetostat, an EHZ2 inhibitor in clinical development, has shown activity in both preclinical models of cancer as well as in patients with lymphoma or INI1-deficient solid tumors. Herein we report the structure-activity relationships from identification of an initial hit in a high-throughput screen through selection of tazemetostat for clinical development. The importance of several methyl groups to the potency of the inhibitors is highlighted as well as the importance of balancing pharmacokinetic properties with potency.

References

Jun 21, 2007·Journal of Biomolecular Screening·Leng A LorBenjamin Schwartz
Dec 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jean-François CoutureRaymond C Trievel
Apr 27, 2010·Current Opinion in Chemical Biology·Natasha ThorneJames Inglese
Aug 3, 2010·The Journal of Biological Chemistry·Paul A Del RizzoRaymond C Trievel
Nov 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Christopher J SneeringerRobert A Copeland
Jun 3, 2011·Chemical Reviews·Eliezer J BarreiroCarlos A M Fraga
Apr 17, 2012·Journal of Medicinal Chemistry·Cheryl S LeungWilliam L Jorgensen
Oct 2, 2012·Nature Chemical Biology·Sarah K KnutsonKevin W Kuntz
Dec 6, 2012·Nature Structural & Molecular Biology·Catherine A MusselmanTatiana G Kutateladze
Dec 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·Wei QiEn Li
Apr 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sarah K KnutsonHeike Keilhack
Dec 13, 2012·ACS Medicinal Chemistry Letters·Sharad K VermaWilliam H Miller
Apr 29, 2015·Nature Chemical Biology·Elayne Chan-PenebreKenneth W Duncan
Jul 21, 2015·Bioorganic & Medicinal Chemistry Letters·Victor S GehlingBrian K Albrecht

❮ Previous
Next ❯

Citations

Aug 23, 2016·Future Medicinal Chemistry·David S RogawskiTomasz Cierpicki
Aug 23, 2016·Future Medicinal Chemistry·Uttara Soumyanarayanan, Brian W Dymock
Jun 20, 2016·Current Opinion in Chemical Biology·Matthieu Schapira, Cheryl H Arrowsmith
Sep 21, 2016·Head and Neck Pathology·Jason K WassermanIlan Weinreb
Jul 12, 2016·Acta Pharmacologica Sinica·Qing Liu, Ming-Wei Wang
Mar 8, 2017·Organic & Biomolecular Chemistry·Min LiuShuang-Feng Yin
Jul 19, 2016·Organic & Biomolecular Chemistry·Daoquan TuChao Jiang
Oct 18, 2018·Chemistry : a European Journal·Yantao Chen
Apr 25, 2018·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Paolo MelliniAntonello Mai
Nov 30, 2018·Expert Review of Proteomics·Dylan M MarchioneJohn Wojcik
Apr 2, 2019·Frontiers in Neuroscience·Eric Murillo-RodríguezAndré Barciela Veras
Aug 28, 2020·Frontiers in Oncology·Marton KönigTorstein R Meling
Feb 7, 2020·International Journal of Molecular Sciences·Anna M ChiarellaNathaniel A Hathaway
Nov 21, 2019·Organic & Biomolecular Chemistry·Andrew R GaleevMichael Rubin
Sep 22, 2020·Beilstein Journal of Organic Chemistry·Benjamin JeffriesBruno Linclau
Sep 16, 2017·The Journal of Biological Chemistry·Lindsay E Moritz, Raymond C Trievel
Sep 3, 2016·Cancer Discovery·Arthur E FrankelJohn D Minna
Oct 22, 2020·Expert Opinion on Therapeutic Patents·Andrew B BenowitzJohn D Harling
Jan 27, 2021·Chemical Communications : Chem Comm·Ying-Qiong GuoXing-Guo Zhang
Dec 24, 2020·Chemical Communications : Chem Comm·Qiu-Zi WuDan-Qian Xu
Mar 21, 2020·Genomics, Proteomics & Bioinformatics·Natalie MezeyKyle K Biggar
Feb 22, 2021·European Journal of Medicinal Chemistry·Shuo YuanBin Yu
Mar 11, 2021·Chemical Society Reviews·Daniya AynetdinovaDarren J Dixon
Mar 30, 2021·Molecular & Cellular Proteomics : MCP·Francesca ZappacostaRoland S Annan
Apr 13, 2021·Journal of Biomedical Science·Kunal Nepali, Jing-Ping Liou
May 28, 2021·The Journal of Organic Chemistry·Andriy I FrolovSergey V Ryabukhin
May 28, 2021·Journal of Medicinal Chemistry·Adam I Green, George M Burslem
Aug 6, 2021·Oncogene·Su H ParkJindan Yu
Apr 18, 2019·Organic Letters·Yuya TsukamotoYasushi Obora
Apr 6, 2018·Journal of Medicinal Chemistry·Robert J Young, Paul D Leeson
Dec 8, 2020·Journal of Medicinal Chemistry·M Cynthia MartinGary E Schiltz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.